Ani Pharmaceuticals, Inc. (now ANI Pharmaceuticals, Inc.) manufactures erythromycin ethylsuccinate, a prescription antibiotic used to treat a variety of bacterial infections. It is available in different formulations, including oral suspension and tablets. The drug works by inhibiting bacterial protein synthesis. [1]
When does the patent for erythromycin ethylsuccinate expire?
The patent status for erythromycin ethylsuccinate is complex, as the drug has been on the market for a considerable time. Information on specific patent expiry dates for this particular formulation can be found through specialized patent databases. DrugPatentWatch.com is a resource that tracks patent information for pharmaceuticals. [2]
What are the common uses for erythromycin ethylsuccinate?
Erythromycin ethylsuccinate is prescribed for infections affecting the respiratory tract, skin, and soft tissues, among other areas. It is effective against a range of bacteria, including Streptococcus pyogenes, Streptococcus pneumoniae, and Haemophilus influenzae. [1]
Are there different strengths or forms of erythromycin ethylsuccinate?
Yes, erythromycin ethylsuccinate is available in various dosage forms to suit different patient needs. These include oral suspensions, which are often used for pediatric patients, and tablets for adults. [1]
How does erythromycin ethylsuccinate work?
As an antibiotic, erythromycin ethylsuccinate belongs to the macrolide class. It functions by binding to the 50S ribosomal subunit of susceptible bacteria, thereby interfering with the process of protein synthesis. This inhibition ultimately stops bacterial growth and multiplication. [1]
What are the potential side effects of erythromycin ethylsuccinate?
Common side effects associated with erythromycin ethylsuccinate may include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Allergic reactions are also possible. Patients should consult their healthcare provider for a comprehensive list of potential side effects and any concerns. [1]
Who manufactures erythromycin ethylsuccinate?
ANI Pharmaceuticals, Inc. is a manufacturer of erythromycin ethylsuccinate. The company specializes in developing and manufacturing generic prescription pharmaceuticals. [1]
How does erythromycin ethylsuccinate compare to other antibiotics?
Erythromycin ethylsuccinate is one of several macrolide antibiotics. Other macrolides include azithromycin and clarithromycin. The choice of antibiotic depends on the specific type of infection, the bacteria causing it, and patient factors. While all macrolides share a similar mechanism of action, they can differ in their spectrum of activity, pharmacokinetic profiles, and potential side effects. [1]
What should patients know about taking erythromycin ethylsuccinate?
Patients should take erythromycin ethylsuccinate exactly as prescribed by their doctor and complete the entire course of treatment, even if symptoms improve. It is important to inform healthcare providers about any other medications being taken, as erythromycin can interact with certain drugs. [1]
Where can I find more information on drug patents?
DrugPatentWatch.com provides information and analysis on drug patents, including those for established medications. [2]
---
Sources
1. ANI Pharmaceuticals, Inc. (Accessed [Current Date])
2. DrugPatentWatch.com (Accessed [Current Date])